← Open Payments lookup

DAWN LINDSEY: Open Payments

NPI 1508216300 · BRYANT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$799 in 39 payments from 11 companies in 2025. Trend: 2023 $255 · 2024 $412 · 2025 $799

Food & beverage: $799
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$269
Lundbeck LLC5$85
Otsuka America Pharmaceutical, Inc.4$81
Neurocrine BioSciences, Inc.4$72
Supernus Pharmaceuticals, Inc.3$63
Axsome Therapeutics, Inc.2$57
Biogen, Inc.3$55
Janssen Pharmaceuticals, Inc2$46
E.R. Squibb & Sons, L.L.C.2$35
Alkermes, Inc.1$20

Products named: CAPLYTA, REXULTI, INGREZZA, Qelbree, Auvelity, ZURZUVAE, SPRAVATO, COBENFY.

Industry payments across AR — which companies pay providers there.